These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32558242)

  • 1. Targeted 595-gene genomic profiling demonstrates low tumor mutational burden in olfactory neuroblastoma.
    Friedman J; Schumacher JK; Papagiannopoulos P; Al-Khudari S; Tajudeen BA; Batra PS
    Int Forum Allergy Rhinol; 2021 Jan; 11(1):58-64. PubMed ID: 32558242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options.
    Gay LM; Kim S; Fedorchak K; Kundranda M; Odia Y; Nangia C; Battiste J; Colon-Otero G; Powell S; Russell J; Elvin JA; Vergilio JA; Suh J; Ali SM; Stephens PJ; Miller VA; Ross JS
    Oncologist; 2017 Jul; 22(7):834-842. PubMed ID: 28495808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genomic profiles and immune microenvironment of olfactory neuroblastoma].
    Yang YY; Liu HG; Li YH; Li XC; Piao YS
    Zhonghua Bing Li Xue Za Zhi; 2024 Sep; 53(9):916-921. PubMed ID: 39231744
    [No Abstract]   [Full Text] [Related]  

  • 4. Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas.
    Topcagic J; Feldman R; Ghazalpour A; Swensen J; Gatalica Z; Vranic S
    PLoS One; 2018; 13(1):e0191244. PubMed ID: 29324814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of p53 gene alterations with tumor progression and recurrence in olfactory neuroblastoma.
    Papadaki H; Kounelis S; Kapadia SB; Bakker A; Swalsky PA; Finkelstein SD
    Am J Surg Pathol; 1996 Jun; 20(6):715-21. PubMed ID: 8651351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent Olfactory Neuroblastoma Treated With Cetuximab and Sunitinib: A Case Report.
    Wang L; Ding Y; Wei L; Zhao D; Wang R; Zhang Y; Gu X; Wang Z
    Medicine (Baltimore); 2016 May; 95(18):e3536. PubMed ID: 27149458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment.
    Czapiewski P; Kunc M; Haybaeck J
    Oncotarget; 2016 Aug; 7(32):52584-52596. PubMed ID: 27256979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence morbidity of olfactory neuroblastoma.
    Melder K; Mace JC; Choby G; Almeida JP; Champagne PO; Chan E; Ciporen J; Chaskes MB; Fernandez-Miranda J; Fung NK; Gardner P; Hwang P; Ji KSY; Kalyvas A; Kong KA; Patel C; Patel Z; Celda MP; Pinheiro-Neto CD; Snyderman C; Thorp BD; Van Gompel JJ; Zenonos G; Zwagerman NT; Sanusi O; Wang EW; Geltzeiler M
    Int Forum Allergy Rhinol; 2024 Sep; 14(9):1435-1445. PubMed ID: 38567900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Molecular Profiling of Olfactory Neuroblastoma Identifies Potentially Targetable
    Lazo de la Vega L; McHugh JB; Cani AK; Kunder K; Walocko FM; Liu CJ; Hovelson DH; Robinson D; Chinnaiyan AM; Tomlins SA; Harms PW
    Mol Cancer Res; 2017 Nov; 15(11):1551-1557. PubMed ID: 28775129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic profiling and immune landscape of olfactory neuroblastoma in China.
    Yang Y; Wan Z; Zhang E; Piao Y
    Front Oncol; 2023; 13():1226494. PubMed ID: 38023213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden.
    Chalmers ZR; Connelly CF; Fabrizio D; Gay L; Ali SM; Ennis R; Schrock A; Campbell B; Shlien A; Chmielecki J; Huang F; He Y; Sun J; Tabori U; Kennedy M; Lieber DS; Roels S; White J; Otto GA; Ross JS; Garraway L; Miller VA; Stephens PJ; Frampton GM
    Genome Med; 2017 Apr; 9(1):34. PubMed ID: 28420421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volumetric analysis of olfactory neuroblastoma skull base laterality and implications on neck disease.
    Marinelli JP; Van Gompel JJ; Link MJ; Moore EJ; Price DL; Lees KA; Kaczor MW; Janus JR
    Laryngoscope; 2018 Apr; 128(4):864-870. PubMed ID: 28833165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the human Achaete-scute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma).
    Carney ME; O'Reilly RC; Sholevar B; Buiakova OI; Lowry LD; Keane WM; Margolis FL; Rothstein JL
    J Neurooncol; 1995 Oct; 26(1):35-43. PubMed ID: 8583243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomography.
    Mori T; Onimaru R; Onodera S; Tsuchiya K; Yasuda K; Hatakeyama H; Kobayashi H; Terasaka S; Homma A; Shirato H
    Radiat Oncol; 2015 Apr; 10():88. PubMed ID: 25888953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient characteristics of olfactory neuroblastoma: experience from a tertiary cancer centre 2000-2016 covering Eastern Denmark.
    Gram SB; Grønhøj C; Mann H; Jakobsen KK; Kiss K; Bilde A; von Buchwald C
    APMIS; 2018 Aug; 126(8):663-666. PubMed ID: 30168622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma.
    Weiss GJ; Liang WS; Izatt T; Arora S; Cherni I; Raju RN; Hostetter G; Kurdoglu A; Christoforides A; Sinari S; Baker AS; Metpally R; Tembe WD; Phillips L; Von Hoff DD; Craig DW; Carpten JD
    PLoS One; 2012; 7(5):e37029. PubMed ID: 22649506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses.
    Larkin RM; Lopez DC; Robbins YL; Lassoued W; Canubas K; Warner A; Karim B; Vulikh K; Hodge JW; Floudas CS; Gulley JL; Gallia GL; Allen CT; London NR
    J Transl Med; 2024 May; 22(1):524. PubMed ID: 38822345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulb.
    Mays AC; Bell D; Ferrarotto R; Phan J; Roberts D; Fuller CD; Frank SJ; Raza SM; Kupferman ME; DeMonte F; Hanna EY; Su SY
    Laryngoscope; 2018 Jun; 128(6):1274-1280. PubMed ID: 29226334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment modalities and outcomes of olfactory neuroblastoma.
    Song CM; Won TB; Lee CH; Kim DY; Rhee CS
    Laryngoscope; 2012 Nov; 122(11):2389-95. PubMed ID: 23070733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed Tomography Image Analysis and Clinical Diagnosis Value of Nasal Olfactory Neuroblastoma.
    Zhang S; Li Q; Zhang F; Xu H; Gao H
    World Neurosurg; 2021 May; 149():333-340. PubMed ID: 33039569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.